Search

everythinglearnresearchcommunity

for

Search:↓

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Spironolactone plus finasteride reduces hirsutism more effectively.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Androgen use may increase the risk of stroke, but more research is needed.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.